Hims & Hers Health, Inc. (HIMS), a health and wellness platform, on Monday announced that its board has authorized a new share repurchase program of up to $250 million in Class A common stock over the next three years
The repurchase follows the full utilization of its prior $100 million program launched in July 2024.
The company said the decision reflects its view that the current market value of its stock may not fully represent its intrinsic value.
In the pre-market trading, Hims & Hers Health is 0.11% higher at $36.98 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.